HIGHLIGHTS
- who: Selin Chiragzada and collaborators from the Biomedical Engineering, Columbia University, New York, USA Mailman School of Public Health, Columbia have published the research work: Review began 09/23/2022 Review ended 11/23/2022 Published 12/01/2022 u00a9 Copyright, in the Journal: (JOURNAL) of December/01,/2022
- what: The results are consistent with the expected benefit of targeted MRI-guided biopsy over a systematic TRUS.
- future: More recent studies continued to confirm the economic impact of premature loss of life.
SUMMARY
Prostate cancer (PCa) is the most . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.